Together, these results indicate that ERα is recruited to the ERE-containing promoters in SLC7A11 and SLC3A2, thereby enhancing SLC7A11 and SLC3A2 expression in response to estrogen stimulation in ER+ breast cancer cells. The gene discussed is SLC3A2; the disease is breast cancer.